- Training
- March 2026
- 2 Days
Russia
€1524EUR$1,751USD£1,299GBP
€1758EUR$2,020USD£1,499GBP
- Training
- June 2024
- 2 Days
Global
From €1660EUR$1,843USD£1,464GBP
- Training
- November 2023
- 2 Days
Global
€3322EUR$3,688USD£2,931GBP
- Training
- May 2023
- 2 Days
Global
From €1660EUR$1,843USD£1,464GBP
- Report
- October 2025
- 22 Pages
Global, China
From €2657EUR$2,950USD£2,345GBP
- Report
- October 2025
- 30 Pages
China, Global
From €2657EUR$2,950USD£2,345GBP
- Book
- July 2008
- 200 Pages
United States
- Book
- June 2002
- 356 Pages
Europe

The Drug Approval market is a key component of the Drug Discovery process. It involves the evaluation of a drug's safety and efficacy by regulatory authorities, such as the US Food and Drug Administration (FDA). This process is essential for the approval of a drug for commercial use. It involves the submission of a New Drug Application (NDA) to the FDA, which includes data from pre-clinical and clinical trials. The FDA then reviews the data and makes a decision on whether to approve the drug. The Drug Approval market is highly competitive, with many companies vying for approval of their drugs.
Companies in the Drug Approval market include pharmaceutical companies such as Pfizer, Merck, and GlaxoSmithKline, as well as biotechnology companies such as Amgen and Genentech. Other companies involved in the market include contract research organizations (CROs) and clinical research organizations (CROs). Show Less Read more